November 2019 – visit to Sweden and launch of women entrepreneurs in Primrose Hill, London
Early November took me to Lund in Sweden, to visit Ziccum. Ziccum is developing new dry-powder versions of the world’s most urgently-needed vaccines. These new, gently air-dried formulations can be transported easily and cost-effectively, with no costly cold storage or refrigeration required. Ziccum’s technology can reduce dependency on the cold chain and therefore greatly improve vaccine accessibility and preparedness.
I had the opportunity to check out their technology first hand.
The company’s patented technology, LaminarPace, develops dry-powder formulations of drugs and vaccines that currently exist in liquid or lyophilized form. By doing so Ziccum can increase the availability of vaccines in existing markets-and open up new ones.
The company is aiming to partner with organisations and stakeholders sharing the view of providing vaccinations to ALL and everybody and who has the capability to add value to this effort.